This standard applies to dosimetry with the radionuclide I-131 in connection with the treatment of benign thyroid diseases with I-131 sodium iodide. The standard describes procedures for the pre-therapeutic determination of the activity with which a planned absorbed dose in the p
DIN 6861-1:2021 history
2021DIN 6861-1:2021 Dosimetry in radionuclide therapy - Part 1: Application of I-131 in benign thyroid diseases
1970DIN 6861-1 E:2020-10 Dosimetry in radionuclide therapy - Part 1: Application of I-131 in benign thyroid diseases